Health

Can Oregon's Senate Bill 951 Cure Healthcare's Corporate Ills?
Corporate & Financial Law Can Oregon's Senate Bill 951 Cure Healthcare's Corporate Ills?

In today's interview, we have the privilege of speaking with Desiree Sainthrope, a legal expert well-versed in the intricacies of trade agreements and global compliance. Today, we'll delve into the significant developments in healthcare policy with the passage of Oregon's Senate Bill 951, which

UK Data Act Transforms Life Sciences and NHS Data Management
Tech & Intellectual Property UK Data Act Transforms Life Sciences and NHS Data Management

The recently enacted Data (Use and Access) Act in the United Kingdom marks a significant departure from previous data protection laws, reconfiguring the landscape for the management of data within the life sciences sector. This legislation introduces a paradigm shift, paving the way for enhanced

Can New York's New Laws Protect Kids From Digital Harm?
Tech & Intellectual Property Can New York's New Laws Protect Kids From Digital Harm?

The digital age has brought countless benefits but also significant challenges, particularly regarding children's safety online. The increasing reliance on digital platforms has raised urgent concerns about data privacy and the mental health impacts of social media. In a bid to safeguard young

Safeguarding Genetic Data Amid 23andMe's Uncertain Future
Regulatory & Administrative Law Safeguarding Genetic Data Amid 23andMe's Uncertain Future

The precarious financial status of 23andMe, a prominent player in the genomic industry, presents a critical challenge, shedding light on the broader concerns of data privacy and security in personal genomics. At the core of this issue lies the fate of the sensitive genetic data of over 14 million

EU's AI Regulations: Catalyst for Clinical Trial Innovation
Tech & Intellectual Property EU's AI Regulations: Catalyst for Clinical Trial Innovation

Recent developments in European Union regulations have precipitated a significant transformation within the clinical trial sector, especially regarding the integration of artificial intelligence. These regulatory changes present both challenges and opportunities for the biopharma industry,

Navigating Telemedicine Policy: Overcoming Legal and Regulatory Challenges
Regulatory & Administrative Law Navigating Telemedicine Policy: Overcoming Legal and Regulatory Challenges

Telemedicine has seen unprecedented growth, especially during the pandemic. However, navigating the complex legal and regulatory landscape remains a significant challenge. This article explores pivotal telemedicine policy trends, legal hurdles, and strategies to enhance telehealth practices in the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later